Literature DB >> 8692918

The structure of bovine F1-ATPase complexed with the antibiotic inhibitor aurovertin B.

M J van Raaij1, J P Abrahams, A G Leslie, J E Walker.   

Abstract

In the structure of bovine mitochondrial F1-ATPase that was previously determined with crystals grown in the presence of adenylyl-imidodiphosphate (AMP-PNP) and ADP, the three catalytic beta-subunits have different conformations and nucleotide occupancies. Adenylyl-imidodiphosphate is bound to one beta-subunit (betaTP), ADP is bound to the second (betaDP), and no nucleotide is bound to the third (betaE). Here we show that the uncompetitive inhibitor aurovertin B binds to bovine F1 at two equivalent sites in betaTP and betaE, in a cleft between the nucleotide binding and C-terminal domains. In betaDP, the aurovertin B pocket is incomplete and is inaccessible to the inhibitor. The aurovertin B bound to betaTP interacts with alpha-Glu399 in the adjacent alphaTP subunit, whereas the aurovertin B bound to betaE is too distant from alphaE to make an equivalent interaction. Both sites encompass betaArg-412, which was shown by mutational studies to be involved in binding aurovertin. Except for minor changes around the aurovertin pockets, the structure of bovine F1-ATPase is the same as determined previously. Aurovertin B appears to act by preventing closure of the catalytic interfaces, which is essential for a catalytic mechanism involving cyclic interconversion of catalytic sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692918      PMCID: PMC38908          DOI: 10.1073/pnas.93.14.6913

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  ANTIBIOTIC STUDIES. II. INHIBITION OF PHOSPHORYL TRANSFER IN MITOCHONDRIA BY OLIGOMYCIN AND AUROVERTIN.

Authors:  H A LARDY; J L CONNELLY; D JOHNSON
Journal:  Biochemistry       Date:  1964-12       Impact factor: 3.162

Review 2.  Inhibitors of the ATP synthethase system.

Authors:  P E Linnett; R B Beechey
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

3.  The binding of aurovertin to mitochondria, and its effect on mitochondrial respiration.

Authors:  R M Bertina; P I Schrier; E C Slater
Journal:  Biochim Biophys Acta       Date:  1973-06-28

4.  Aurovertin, a fluorescent probe of conformational change in beef heart mitochondrial adenosine triphosphatase.

Authors:  T Chang; H S Penefsky
Journal:  J Biol Chem       Date:  1973-04-25       Impact factor: 5.157

5.  Effect of aurovertin on energy-linked processes related to oxidative phosphorylation.

Authors:  G Lenaz
Journal:  Biochem Biophys Res Commun       Date:  1965-10-26       Impact factor: 3.575

6.  Citreoviridins from Aspergillus terreus.

Authors:  B Franck; H P Gehrken
Journal:  Angew Chem Int Ed Engl       Date:  1980       Impact factor: 15.336

7.  Aurovertin binds to the beta subunit of yeast mitochondrial ATPase.

Authors:  M G Douglas; Y Koh; M E Dockter; G Schatz
Journal:  J Biol Chem       Date:  1977-12-10       Impact factor: 5.157

8.  Citreoviridin, a specific inhibitor of the mitochondiral adenosine triphosphatase.

Authors:  P E Linnett; A D Mitchell; M D Osselton; L J Mulheirn; R B Beechey
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

9.  The binding of aurovertin to isolated beta subunit of F1 (mitochondrial ATPase). Stoicheiometry of beta subunit in F1.

Authors:  G J Verschoor; P R van der Sluis; E C Slater
Journal:  Biochim Biophys Acta       Date:  1977-11-17

10.  A comparison of the effects of NN'-dicyclohexylcarbodi-imide, oligomycin A and aurovertin on enrgy-linked reactions in mitochondria and submitochondrial particles.

Authors:  A M Roberton; C T Holloway; I G Knight; R B Beechey
Journal:  Biochem J       Date:  1968-07       Impact factor: 3.857

View more
  54 in total

Review 1.  Bioenergetics of the Archaea.

Authors:  G Schäfer; M Engelhard; V Müller
Journal:  Microbiol Mol Biol Rev       Date:  1999-09       Impact factor: 11.056

Review 2.  Structural model of F1-ATPase and the implications for rotary catalysis.

Authors:  A G Leslie; J E Walker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-04-29       Impact factor: 6.237

3.  Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.

Authors:  Monika Deshpande; Luigi Notari; Preeti Subramanian; Vicente Notario; S Patricia Becerra
Journal:  Int J Oncol       Date:  2012-04-10       Impact factor: 5.650

4.  Mitochondrial F(0) F(1) -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone.

Authors:  S Cumero; F Fogolari; R Domenis; R Zucchi; I Mavelli; S Contessi
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 5.  Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides.

Authors:  Zulfiqar Ahmad; Thomas F Laughlin
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  Inhibition sites in F1-ATPase from bovine heart mitochondria.

Authors:  Jonathan R Gledhill; John E Walker
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

Review 7.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

8.  Functional halt positions of rotary FOF1-ATPase correlated with crystal structures.

Authors:  Hendrik Sielaff; Henning Rennekamp; Siegfried Engelbrecht; Wolfgang Junge
Journal:  Biophys J       Date:  2008-08-22       Impact factor: 4.033

9.  Conformational dynamics of the F1-ATPase beta-subunit: a molecular dynamics study.

Authors:  Rainer A Böckmann; Helmut Grubmüller
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

10.  Effect of polyphenolic phytochemicals on ectopic oxidative phosphorylation in rod outer segments of bovine retina.

Authors:  Daniela Calzia; Michele Oneto; Federico Caicci; Paolo Bianchini; Silvia Ravera; Martina Bartolucci; Alberto Diaspro; Paolo Degan; Lucia Manni; Carlo Enrico Traverso; Isabella Panfoli
Journal:  Br J Pharmacol       Date:  2015-06-16       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.